University of Wisconsin–Madison–led researchers report lower yet statistically non-significant recurrence of Clostridioides ...

The Food and Drug Administration (FDA) has approved Tyzavan ™ (vancomycin injection, USP), a novel ready-to-infuse, room temperature stable formulation of vancomycin, for the treatment of various ...

Vancomycin appeared to top placebo for lowering Clostridioides difficile infection (CDI) recurrence rates in patients taking ...

Fecal microbiota transplantation was not inferior to vancomycin for the treatment of primary Clostridioides difficile ...

Hikma Pharmaceuticals PLC (Hikma), the multinational pharmaceutical company, today announced the approval of a novel formulation of the first-of-its-kind, ready-to-infuse formulation of vancomycin, ...

Vancomycin has only rarely been implicated as a cause of thrombocytopenia, and there is only limited evidence that this complication is caused by immune mechanisms. We conducted a study to determin ...

Vancomycin flushing syndrome (VFS) is a reaction to the antibiotic drug vancomycin. Common symptoms consist of a rash that itches during or after the infusion of vancomycin. VFS is the most common ...

The addition of vancomycin to beta-lactam prophylaxis in arthroplasty may reduce surgical-site infections; however, the efficacy and safety are unclear.In this multicenter, double-blind, superiorit ...

Vancomycin remains one of the most widely used antibiotics for the treatment of Staphylococcus (including methicillin-resistant Staphylococcus aureus), Streptococcus, and Enterococcus infections.

Vancomycin is a generic prescription drug that’s used to treat certain types of bacterial infections in adults and children. Vancomycin’s cost may depend on factors such as your dosage ...